Business Wire

SUNAMACHI-ELEMENTARY

14.12.2020 15:32:18 CET | Business Wire | Press release

Share
Tokyo Elementary School Uses Animal Crossing: New Horizons for Special SDG-focused Open Class

The Floating City, a virtual island created within the popular Nintendo Switch game Animal Crossing: New Horizons (ACNH) , is providing elementary schools with a platform for special lessons on the theme of SDGs. Led by the 6th Sunamachi Elementary School in Koto-ku, Tokyo, the initiative kicked off on December 10 with a special open class titled “Special Lessons in ACNH .” Participating children visited The Floating City for an opportunity to learn about environmental issues via the game.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005513/en/

The Floating City is a virtual floating island launched within ACNH on December 8, 2020, with supervision from one co-founder of Blue Frontiers, a sustainable property developer currently working toward the creation of a real-world sustainable floating island in the Southern Hemisphere. The in-game island’s content is designed to boost interest in environmental issues among the younger generation, leveraging gameplay to encourage them to think about the future.

Special Lessons in ACNH at Koto-ku 6th Sunamachi Elementary School, Grade 5

The special open class saw participation from 30 children at Tokyo’s 6th Sunamachi Elementary School. The Floating City within ACNH is home to numerous animals, including some endangered species, and the virtual island also incorporates various activities for fun, guided learning.

Children actively asked questions in the session, which focused on current global environmental issues and was led by fisheries scientist Dr. Hiroaki Chiba, an associate professor at Kitasato University. After the lesson, Dr. Chiba commented, “Learning about the environment through games is a great educational tool which creates an opportunity to think about environmental issues and the future.”

The Floating City lets children experience environmental issues through ACNH

In the special lesson, children experienced The Floating City within ACNH through gameplay, deepening their understanding of environmental issues while visiting the island’s various virtual facilities. They learned about sustainable living on The Floating City, which echoes a real floating island, with a wind farm to create electricity through the power of nature and a restaurant serving dishes prepared only from ingredients grown on the island. The game also provides enjoyable opportunities to experience environmental issues, such as visiting a museum of endangered animals and talking with an African elephant. Children were excited by the fishing and bug-catching activities, and enthralled by the island’s many unique features.

Lesson topics: Global environmental issues and the future of fish

Dr. Hiroaki Chiba joined as a special guest instructor and delivered a lesson on what can be done to resolve current environmental issues and marine pollution. Beginning with an explanation of the serious environmental impacts of rising carbon dioxide levels, he described how Japan’s abundant ocean ecosystem has been disrupted by global warming and the acidification of seawater caused by this greenhouse gas, as well as by overfishing.

Dr. Chiba also raised the pressing issue of ocean plastic pollution, pointing out that the cumulative amount of plastic waste in the world is predicted to exceed 12 billion tons by 2050. These plastics are the source of countless “microplastic” particles that cannot be broken down by waves or ultraviolet rays, and even hold the potential to turn oceans into a plastic “soup” uninhabitable to fish. When asked by the children about fish populations around the world, Dr. Chiba explained that fish numbers are decreasing worldwide due to shrinking habitats for cold-water fish caused by global warming and rising sea temperatures.

Finally, students studied the adverse impacts of environmental damage on humans. They learned what they can do to be more eco-friendly and help prevent marine pollution, including practicing the three R’s (reduce, reuse, recycle) and purchasing ecolabelled products.

About The Floating City and Blue Frontiers

Floating cities are a pioneering sustainability solution whose potential to combat various environmental issues has even seen them discussed by a UN-Habitat roundtable. The rich natural surroundings of this in-game recreation have numerous features designed to help users enjoy learning about sustainability and environmental issues––from the many animals representing endangered species who welcome visitors to the island, to fishing and bug-catching activities that generate a warning when users catch more than they need. The Floating City’s guided learning opportunities even include a museum dedicated to extinct animals and a restaurant with a menu that spotlights disappearing ingredients.

The Floating City was created under the supervision of one co-founder of Blue Frontiers, a company that aims to build an environmentally friendly, sustainable floating island in the near future. Visit https://www.blue-frontiers.com/en/ for more information.

Applying for a special lesson

The Floating City is accepting applications from elementary schools interested in hosting special lessons as described above. If your school would like to participate, please email contact@the-floatingcity.com .

Visiting The Floating City

Lie down in your own in-game bed and enter the Dream Address code (DA-8310-5913-5018) to pay a visit to the island.

What you need to visit The Floating City for an in-game guided tour:

  • Nintendo Switch on which to play Animal Crossing: New Horizons
  • In-game airport access
  • Nintendo Switch Online subscription
  • Communicative competence in English or Japanese

What you need to visit The Floating City for a non-guided trip:

  • Nintendo Switch on which to play Animal Crossing: New Horizons
  • Access to in-game dreaming feature
  • Nintendo Switch Online subscription

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye